Clinical Trial: A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07705334) titled 'A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors' on July 01.

Brief Summary: This is a Phase 1, first-in-human (FIH), open-label, multicenter study designed to evaluate the safety, tolerability, PK, and preliminary anti-tumor activity of SHY-ONC6 in participants with advanced or metastatic solid tumors who have progressed on or are intolerant to standard therapies. The study will consist of 2 parts: a dose escalation part (Phase 1a) and a dose expansion part (Phase 1b).

Study Start Date: June 29

Study Type: INTERVENTIONAL

Condition: Advanced or Metastatic Solid Tumors Triple N...